Back to Journals » Vascular Health and Risk Management » Volume 11 » default
![](https://www.dovepress.com/cr_data/cache/journal_image/2/cope/thumb_100_1000_100.jpg)
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1524)
- Volume 20, 2024 (28)
- Volume 19, 2023 (86)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 11, 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Fractional flow reserve-guided percutaneous coronary intervention: where to after FAME 2?
van de Hoef TP, Meuwissen M, Piek JJ
Vascular Health and Risk Management 2015, 11:613-622
Published Date: 3 December 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Personalized medicine and stroke prevention: where are we?
Kim J, Thrift AG, Nelson MR, Bladin CF, Cadilhac DA
Vascular Health and Risk Management 2015, 11:601-611
Published Date: 2 December 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Preseason preparation training and endothelial function in elite professional soccer players
Androulakis NE, Koundourakis NE, Nioti E, Spatharaki P, Hatzisymeon D, Miminas I, Alexandrakis MG
Vascular Health and Risk Management 2015, 11:595-599
Published Date: 26 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
Blaes AH, Rehman A, Vock DM, Luo X, Menge M, Yee D, Missov E, Duprez D
Vascular Health and Risk Management 2015, 11:591-594
Published Date: 24 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine
Herath HMM, Weerarathna TP, Umesha D
Vascular Health and Risk Management 2015, 11:583-589
Published Date: 13 November 2015
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/6H2atAo-Tmo/1.jpg)
Okeahialam BN
Vascular Health and Risk Management 2015, 11:579-581
Published Date: 6 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
Pfohl M, Siegmund T, Pscherer S, Pegelow K, Seufert J
Vascular Health and Risk Management 2015, 11:569-578
Published Date: 6 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
Sangsawang T, Sriwijitkamol A
Vascular Health and Risk Management 2015, 11:563-567
Published Date: 4 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Managing atrial fibrillation in the very elderly patient: challenges and solutions
Karamichalakis N, Letsas KP, Vlachos K, Georgopoulos S, Bakalakos A, Efremidis M, Sideris A
Vascular Health and Risk Management 2015, 11:555-562
Published Date: 27 October 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study
Bosevski M, Stojanovska L
Vascular Health and Risk Management 2015, 11:549-553
Published Date: 16 October 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A comparative cohort study of totally laparoscopic and open aortobifemoral bypass for the treatment of advanced atherosclerosis
Kazmi SS, Jørgensen JJ, Sundhagen JO, Krog AH, Flørenes TL, Kollerøs D, Abdelnoor M
Vascular Health and Risk Management 2015, 11:541-547
Published Date: 18 September 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The MGuard coronary stent: safety, efficacy, and clinical utility
Gracida M, Romaguera R, Jacobi F, Gómez-Hospital JA, Cequier A
Vascular Health and Risk Management 2015, 11:533-539
Published Date: 18 September 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
LDL electronegativity index: a potential novel index for predicting cardiovascular disease
Ivanova EA, Bobryshev YV, Orekhov AN
Vascular Health and Risk Management 2015, 11:525-532
Published Date: 28 August 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparison of bioavailability of krill oil versus fish oil and health effect
Ulven SM, Holven KB
Vascular Health and Risk Management 2015, 11:511-524
Published Date: 28 August 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparing withdrawal and not withdrawal of life-sustaining treatment among patients who died from stroke
Helvig E, Thomassen L, Waje-Andreassen U, Naess H
Vascular Health and Risk Management 2015, 11:507-510
Published Date: 3 September 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?
Noubiap JJ, Nansseu JR
Vascular Health and Risk Management 2015, 11:503-506
Published Date: 25 August 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New developments in atherosclerosis: clinical potential of PCSK9 inhibition
Giunzioni I, Tavori H
Vascular Health and Risk Management 2015, 11:493-501
Published Date: 24 August 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
Blann A
Vascular Health and Risk Management 2015, 11:489-492
Published Date: 20 August 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Subcutaneous adipose tissue plays a beneficial effect on subclinical atherosclerosis in young survivors of acute lymphocytic leukemia
Siviero-Miachon AA, Spinola-Castro AM, Lee ML, Monteiro CM, Carvalho AC, Calixto AR, Geloneze B, Guerra-Junior G
Vascular Health and Risk Management 2015, 11:479-488
Published Date: 18 August 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prevention of venous thromboembolism in patients undergoing bariatric surgery
Bartlett MA, Mauck KF, Daniels PR
Vascular Health and Risk Management 2015, 11:461-477
Published Date: 17 August 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Assessing the risk of recurrent venous thromboembolism – a practical approach
Fahrni J, Husmann M, Gretener SB, Keo HH
Vascular Health and Risk Management 2015, 11:451-459
Published Date: 17 August 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Secondary stroke prevention: challenges and solutions
Esenwa C, Gutierrez J
Vascular Health and Risk Management 2015, 11:437-450
Published Date: 7 August 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sex differences in predictors of ischemic stroke: current perspectives
Samai AA, Martin-Schild S
Vascular Health and Risk Management 2015, 11:427-436
Published Date: 27 July 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database
Detournay B, Halimi S, Robert J, Deschaseaux C, Dejager S
Vascular Health and Risk Management 2015, 11:417-425
Published Date: 17 July 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Preeclampsia: long-term consequences for vascular health
Amaral LM, Cunningham Jr MW, Cornelius DC, LaMarca B
Vascular Health and Risk Management 2015, 11:403-415
Published Date: 15 July 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Feasibility and safety of rehabilitation after venous thromboembolism
Noack F, Schmidt B, Amoury M, Stoevesandt D, Gielen S, Pflaumbaum B, Girschick C, Völler H, Schlitt A
Vascular Health and Risk Management 2015, 11:397-401
Published Date: 13 July 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence
![](cr_data/cache/submission_images/s70000/70229/figure_3_200_200_90.jpg)
Bishu K, Armstrong EJ
Vascular Health and Risk Management 2015, 11:387-395
Published Date: 13 July 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Preoperative optimization of the vascular surgery patient
Zhan HT, Purcell ST, Bush RL
Vascular Health and Risk Management 2015, 11:379-385
Published Date: 1 July 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of diclofenac in the prevention of postpericardiotomy syndrome after cardiac surgery
Sevuk U, Baysal E, Altindag R, Yaylak B, Adiyaman MS, Ay N, Alp V, Beyazit U
Vascular Health and Risk Management 2015, 11:373-378
Published Date: 30 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Physical activity in patients with type 2 diabetes and hypertension – insights into motivations and barriers from the MOBILE study
Duclos M, Dejager S, Postel-Vinay N, di Nicola S, Quéré S, Fiquet B
Vascular Health and Risk Management 2015, 11:361-371
Published Date: 29 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Heart rate variability and arrhythmic patterns of 24-hour Holter electrocardiography among Nigerians with cardiovascular diseases
Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Ajayi OE, Adeyeye VO, Mene-Afejuku TO, Bamikole OJ, Ogunyemi SA, Ajibare AO, Oketona OA
Vascular Health and Risk Management 2015, 11:353-359
Published Date: 29 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism
Chan NC, Bhagirath V, Eikelboom JW
Vascular Health and Risk Management 2015, 11:343-351
Published Date: 26 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lipidomics in vascular health: current perspectives
Kolovou G, Kolovou V, Mavrogeni S
Vascular Health and Risk Management 2015, 11:333-342
Published Date: 12 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
Ment J
Vascular Health and Risk Management 2015, 11:317-332
Published Date: 10 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Blood pressure control to prevent decline in cognition after stroke
Ihle-Hansen H, Thommessen B, Fagerland MW, Øksengård AR, Wyller TB, Engedal K, Fure B
Vascular Health and Risk Management 2015, 11:311-316
Published Date: 9 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore
Setia S, Fung SSW, Waters DD
Vascular Health and Risk Management 2015, 11:303-310
Published Date: 4 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
High-flow bypass and wrap-clipping for ruptured blood blister-like aneurysm of the internal carotid artery using intraoperative monitoring of cerebral hemodynamics
![](cr_data/cache/submission_images/s73000/73779/fig1_200_200_90.jpg)
Kubo Y, Koji T, Yoshida K, Saito H, Ogawa A, Ogasawara K
Vascular Health and Risk Management 2015, 11:297-302
Published Date: 3 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
Singh JSS, Lang CC
Vascular Health and Risk Management 2015, 11:283-295
Published Date: 1 June 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current and emerging strategies in the management of venous thromboembolism: benefit–risk assessment of dabigatran
Fanola CL
Vascular Health and Risk Management 2015, 11:271-282
Published Date: 27 May 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Epoprostenol sodium for treatment of pulmonary arterial hypertension
Saito Y, Nakamura K, Akagi S, Sarashina T, Ejiri K, Miura A, Ogawa A, Matsubara H, Ito H
Vascular Health and Risk Management 2015, 11:265-270
Published Date: 14 May 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lipid-modifying therapy in the elderly
Hamilton-Craig I, Colquhoun D, Kostner K, Woodhouse S, d'Emden M
Vascular Health and Risk Management 2015, 11:251-263
Published Date: 14 May 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparison of the BPLab® sphygmomanometer for ambulatory blood pressure monitoring with mercury sphygmomanometry in pregnant women: validation study according to the British Hypertension Society protocol
Dorogova IV, Panina ES
Vascular Health and Risk Management 2015, 11:245-249
Published Date: 13 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Alogliptin benzoate for management of type 2 diabetes
Saisho Y
Vascular Health and Risk Management 2015, 11:229-243
Published Date: 10 April 2015
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/pB34ko3pLak/1.jpg)
Sandoo A, Kitas GD, Carmichael AR
Vascular Health and Risk Management 2015, 11:223-228
Published Date: 7 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Endovascular repair of a life-threatening radiation-induced ruptured false aneurysm of the intrathoracic left subclavian artery: case report
![](cr_data/cache/submission_images/s76000/76012/12_jan_2015_figure_3_200_200_90.jpg)
Hizette P, Horn D, Lemaitre J, Segers B
Vascular Health and Risk Management 2015, 11:219-222
Published Date: 31 March 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Experimental study of sutureless vascular anastomosis with use of glued prosthesis in rabbits
![](cr_data/cache/submission_images/s73000/73104/17_sep_2014_fig3_200_200_90.jpg)
Vokrri L, Qavdarbasha A, Rudari H, Ahmetaj H, Manxhuka-Kërliu S, Hyseni N, Porcu P, Cinquin P, Sessa C
Vascular Health and Risk Management 2015, 11:211-217
Published Date: 27 March 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
Scherer DJ, Nicholls SJ
Vascular Health and Risk Management 2015, 11:203-209
Published Date: 25 March 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Virtual reality simulation for the optimization of endovascular procedures: current perspectives
![](cr_data/cache/submission_images/s46000/46194/09_oct_2014_fig_3_200_200_90.jpg)
Rudarakanchana N, Van Herzeele I, Desender L, Cheshire NJW
Vascular Health and Risk Management 2015, 11:195-202
Published Date: 10 March 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease
Chen DC, Armstrong EJ, Singh GD, Amsterdam EA, Laird JR
Vascular Health and Risk Management 2015, 11:185-193
Published Date: 3 March 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms
Vacek TP, Rehman S, Neamtu D, Yu S, Givimani S, Tyagi SC
Vascular Health and Risk Management 2015, 11:173-183
Published Date: 27 February 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control
Bays HE, Brinton EA, Triscari J, Chen E, Maccubbin D, MacLean AA, Gibson KL, Ruck RA, Johnson-Levonas AO, O’Neill EA, Mitchel YB
Vascular Health and Risk Management 2015, 11:165-172
Published Date: 24 February 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Strokes in young adults: epidemiology and prevention
Smajlović D
Vascular Health and Risk Management 2015, 11:157-164
Published Date: 24 February 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study
Saab C, Al-Saber FA, Haddad J, Jallo MK, Steitieh H, Bader G, Ibrahim M
Vascular Health and Risk Management 2015, 11:149-155
Published Date: 24 February 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Platelet function tests: a comparative review
Paniccia R, Priora R, Alessandrello Liotta A, Abbate R
Vascular Health and Risk Management 2015, 11:133-148
Published Date: 18 February 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia – a review of its characteristics
Ramadan WH, Kabbara WK
Vascular Health and Risk Management 2015, 11:125-132
Published Date: 11 February 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The role of factor Xa inhibitors in venous thromboembolism treatment
Cabral KP, Ansell JE
Vascular Health and Risk Management 2015, 11:117-123
Published Date: 30 January 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes
Joseph JJ, Donner TW
Vascular Health and Risk Management 2015, 11:107-116
Published Date: 28 January 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prevention of stent thrombosis: challenges and solutions
Reejhsinghani R, Lotfi AS
Vascular Health and Risk Management 2015, 11:93-106
Published Date: 27 January 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Scaffolds in vascular regeneration: current status
Thottappillil N, Nair PD
Vascular Health and Risk Management 2015, 11:79-91
Published Date: 19 January 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho BL, Ueng KC, DiTommaso S, Shete A
Vascular Health and Risk Management 2015, 11:71-78
Published Date: 21 January 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Adiponectin as a potential biomarker of vascular disease
Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, Fallah P, Bazi Z
Vascular Health and Risk Management 2015, 11:55-70
Published Date: 16 January 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Validation of two automatic devices for the self-measurement of blood pressure according to the ANSI/AAMI/ISO81060-2:2009 guidelines: the Omron BP765 (HEM-7311-ZSA) and the Omron BP760N (HEM-7320-Z)
Takahashi H, Yoshika M, Yokoi T
Vascular Health and Risk Management 2015, 11:49-53
Published Date: 9 January 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus
Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA
Vascular Health and Risk Management 2015, 11:35-48
Published Date: 6 January 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both
Ghushchyan V, Nair KV, Page RL II
Vascular Health and Risk Management 2015, 11:25-34
Published Date: 24 December 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease
Toth PP
Vascular Health and Risk Management 2015, 11:9-23
Published Date: 23 December 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice
Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE
Vascular Health and Risk Management 2015, 11:1-8
Published Date: 17 December 2014